Innovation Theories Of Harm Are Crucial In Merger Control

By Can Celiktemur, Peter Davis and Pradeep Venkatesh (May 21, 2018, 3:03 PM EDT) -- The European Commission analyzed whether incentives to invest in innovation would reduce following the mergers in both Dow/DuPont and Bayer/Monsanto. In this article we describe why innovation theories of harm, or ToHs, are important in merger control, how they relate to conventional merger analysis, and the challenges for agencies seeking to pursue a more comprehensive approach....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!